犠 II
SARS SARS ( I
...I... II...III...VI... VII... 1... 1... 5... 8... 11... 11... 12... 16... 18... 23... 27... 29... 31... 36 ( )... 42... 55... 55... 58... 63... 73... 75... 75... 77... 82... 88... 88 III
... 89... 98... 105... 108... 108... 109... 111... 112... 113... 115... 115... 117... 118... 121... 125... 125... 127... 130 SARS... 133 2003 SARS... 135 SARS... 137 SARS... 149... 152 SARS... 153... 154... 156... 163 ( )... 170 A... 174... 174... 174... 174 (SHIFTING THE BURDEN)... 175... 176... 177... 178 IV
... 179 B 2003 SARS... 181 2003 SARS... 181 SARS... 182 SARS... 185 SARS... 187 SARS... 191 SARS... 192 SARS... 197 V
4.2 SARS... 146 4.2 SARS SWOT... 147 3.2 LANCET SARS... 186 3.2 2SARS... 188 3.2 3SARS... 193 VI
2.1 1... 78 2.1 2... 78 2.1 3... 79 2.1 4... 80 2.1 5... 80 2.1 6... 83 2.1 8... 84 2.1 9... 84 2.1 10... 85 2.1 11... 87 2.1 12... 87 2.2 1... 176 2.2 2... 177 2.2 3... 178 2.2 4... 179 2.2 5... 180 3.1 1 SARS... 181 3.1 2 SARS... 182 VII
抛 1
峯 2
3
抛 4
5
(2000) (2000) (2000) (2001 6
2001 5 (2002) ( ) (2003) (2003 (2004 7
闘 SARS SARS 8
( ) 9
偱 敎 2003 SARS ( )SARS 10
11 (538-597) 5 575 6 ( ) ( ) ( 7 8 (
( (538~597 ) (515~577 (~668 ) ( ) SARS ( Nagarjuna 12
13
(409) 14 却 14
16 100 (402) 15
1 19 ( ) 16
(534-558) 17
(515-577) ( 529) 逈 18
28 ( 澁 ) 迹 却 却 郷 19
廸 30 ( 548) (553) 31 (554) (555) (556) (557) (558) (568) 33 20
21 34 (577).
38 39 22
( ) (538-598) ( ) (538) (598 23
24 17 43 (560) (560) 44 45 (56 (575) ( 574)
25 46 (575) 47 (585) (591) (592) (593-594) (595) (596) 48 (597)
49 50 51 迹 52 ( 598 1 7 ( ) 刹 (605) 8 26
30 27
( ) 54 (2002) 28
敍 29
58 30
31
麁 1. 32
2. 3. 4. 5. 33
34
卧 2 35
36 ( ) ( ) ( ) ( ) ( ) ( ) 2 ( ) 5 2
疎 竪 37
(2000) 38
82 5 84 ( ) ( ) 39
4 40
41
( ) 徧 42
竪 5 43
1 5 1.. 3 2 44
55 2. 3 3 3. 1 45
( ) 46
1 麁 麁 麁 47
5 2 48
15 49
2 3 1 2 50
3 ( ) 3 3 51
1 麁 麁 1 52
53
1 10 4 5 54
55 ( ) (1) (2) (3)
(4) 146 顚 56
2 57
58
1. 2. 59
3. 4. 5. 6. 60
7. 閲 61
8. 9. (2002) 62
63
却 却 64
没 却 刧 65
没 66
呪 67
脚 覩 覩 68
7 : 脇 69
70
隣 71
竪 72
73
(1) (2) (3) (4) (5) 羣. (2004) SARS 74
担 ( ( ) 4 (system) sunistamai ( ) 75
(cybernetics) (Gregory Bateson) (Russell Ackoff) (Eric Trist) (Ludwigvon Bertallanfy) (Santa Fe Institute)) (structure) struere ( ) (detail complexity (dynamic complexity) 76
2.11 77
2.11 ( ) (2.12) 2.12 78
2.13 2.13 踪 ( ) 79
( 2.14 ) 2.14 ( 2.15 ) 2.15 80
2.10 81
(reinforcing feedback) ( ) 82
2.16 2.16 ( 2.16 ( ) (balancing feedback) ( ) 83
2.18 ( ) 2.18 (2.1 9) 2.19 84
2.110 ( ) 2.110 2.110 85
. 2.111 2.111 86
2.112 2.111 2.112 (systems archetype) 87
(archetype ) B 88
却 Lorenz 1962 The Butterfly Effect 却 却 89
2005 78 CRASH 奬 却 緃 却 騒 90
却 1946 1949 5 4 (Mlilton Friedman) (Money Mischief) 300%3 91
Yt+1=Yt2 Y1=1 Y30=? Y30=1 Yt+1=Yt2 Y1=1.0000001 Y30=? Y30=207017139865568000000000 Y1=1.0000001 207017139865568000000000 92
Y23=1.52 Y23 1.52 76.6% 207017139865568000000000 没 Y23=1.52 2001 9 11 3000 93
担 911 ( ) 94
没 没 ( ) 24 14 7 http://udn.com 95
Y=1.52 1918 2003 96
SARS Council on Foreign Relations, CFR 2005 7 8 97
CDC SARS SARS SARS 98
抛 99
100
230 600 62% 52 1939 101
911 担 231 102
103 2005 3 9 13
1/3 76 6 35% 40% (Lancet) 1994 (NIH)2000 5 104
105
郷 郷 60 担 郷 没 郷 郷 10 却 106
毎 ( ) ( ) ( ) ( ) 107
( ) 108
(The Club of Rome) (Peter M.Senge) (2004) 109
1. 2. 3. 110
(. 111
2003 SARS SARS 24 112
繋 汚 113
没 114
( ) 115
116
20 A.1 117
逹 118
刹 刧 1. 119
2. ( ) 3. 4. 8 澁 120
( ) 4 121
2 亁 逹 却 堃 (2006 5 ) 33 122
堃 1. 2. (MBSR) 255 2004 240 3. (chronic pain) ( ) (cancer) (AIDS) 堃 123
(fibromyalgia) (multiple sclerosis) (anxiety) (panic) (obsessive compulsive) (binge eating disorder) 4. 5. 256 6. (Stanford University Medical Center) (University of Wisconsin Hospital andclinics) 257 (Hall :2003) (BBC NEWS: 2003) 緖 緖 堃 堃 124
2006 3 82 却 1976 堃 125
偒 259 2-3 鈎 29 却 XXX 没 126
却 ( ) ( ) 127
128 却 却 105 ( )
, () ( ) 汚 129
( ) 1 麨 130
8 塠 8 呪 5 131
(Thorwald Dethlefsen) (Rudiger Dahlke)(2002) 132
SARS SARS 2003 3 133
SARS SARS SARS SARS SARS SARS SARS SARS SARS 担 1139 37 SARS SARS SARS SARS SARS SARS 134
SARS SARS SARS SARS SARS SARS 2003 SARS 2003 SARS SARS 刧 SARS SARS 2003 3 12 (WHO) 3 15 WHO (Severe Acute Respiratory Syndrome, SARS) WHO (SARS ) 2003 4 12 21 2960 SARS 119 WHO 269 SARS 2003 4 135
掲 (2003 6 1 ) 敍 SARS SARS SAR 270 敍 却 没 136
SARS 却 SARS SARS 却 2003 SARS 2003 SARS 4044 2003 SARS SARS SARS B 2003 SARS SARS SARS 137
却 却 SARS BSARS SARS SARS SARS SARS 2002 11 16 SARS 2003 3 2003 SARS SARS SARS 22 2003 6 SARS 138
139
1. SARS 2. SARS 3. 140
4. SARS SARS SARS SARS 抛 SARS 2005 10 05 2005-10-05(ENS) SARS SARS 141
400 SARS 揺 SARS SARS SARS SARS SARS BSARS 2003 5 254 SARS 13 SARS SARS SARS 241 142
70% 48% 34% 94% 69 (29%) SARS N95 30% SARS SARS SARS SARS CA112 SARS 却 CA112 21 没 SARS SARS ( ) 275 SARS (WHO) SARS Klaus Stohr (2003 5 4 ) 143
SARS SARS (over-reaction) 20 SARS Mark Salter SARS SARS 却 SARS SARS 2006 6 14 SARS SARS SARS 144
SARS SARS SARS SARS SARS SARS SARS 145
SARS 4.2 SARS ( ) 2003 SARS SWOT SARS 146
SWOT 4.22 4.2 SARS SWOT (Opportunities) (Threats) 1. 2003 SARS 1. SARS SARS SARS 2. 2003 2. SARS SARS SARS 徴 SARS 3. SARS 4. 5. SARS SARS (Strength) (Weakness) 1. 1. 2. SARS 2. 3. 4. 147
5. SARS SARS 1. SARS SARS 2. 3. 3 SARS SARS 148
SARS 3035 SARS SARS SWOT SARS () () SARS 280 281 149
14 282 283 284 刼 2003 SARS SARS SARS 150
SARS SARS 1665 151
2003 SARS SARS SARS SARS SARS 2003 SARS (Y=1.52 ) SARS SARS SARS 152
SARS SARS SARS 汚 B SARS ( ) (1) (11) 1 2 (1) (7). 7 却 SARS SAR 没 153
汚 SARS 没 B SARS SARS SARS 輰 (1997) 154
SARS 没 SARS 汚 汚 汚 汚 却 徧 徧 155
没 SARS. SARS () 卧 SARS. 156
3 288 camatha vipacyana 1 289 1 290 292 157
腭 瘇 脚 脚 脚 脚 脚 158
299 Bernie Siegel SARS SARS 159
8 27 160
8 161
( 澁 ) 迹 澁 162
( ) 163
Robert G.Allen Your Health is in Danger Robert G.Allen 寃 却 Y=1.52 黄 却 164
165 Y1=1.0000001 Y=1.52 黄 ( ) ( ) SARS
166 SARS ( SARS ( )
SARS SARS SARS SARS 没 SARS 亁 SARS 167
SARS SARS 2003 SARS SARS 踪 SARS SARS SARS SARS SARS SARS SARS SARS WTO 2006 6 30 H5N1 203 H5N1 2003 12 113 3 75 10 29 168
50 1918 1919 169
( ) 10 (CBETA, T09, no. 278, p. 465, c2629) (CBETA, T55, no. 2149, p. 283, c17~30) (CBETA, T25, no. 1509, p. 401, a25~27) 4 (CBETA, T30, no. 1564, p. 33, b1114) 2 (CBETA, T42, no. 1824, p. 20, b13) 1 (CBETA, T08, no. 246, p. 835, c1517) 1 (CBETA, T51, no. 2069, p. 99, b2224) (CBETA, T55, no. 2178, p. 1136, a10~23) 1 (CBETA, T46, no. 1913, p. 452, c28p. 453, a2) (CBETA, T46, no. 1912) 4 (CBETA, T46, no. 1918, p. 578, c1426) (CBETA, T42, no. 1827) (CBETA, T49, no. 2035, p. 184, c28~p. 185, a29) 2 (CBETA, T33, no. 1716, p. 696, a1518) (CBETA, T33, no. 1717) 1 (CBETA, T46, no. 1926, p. 698, a812) 1 (CBETA, T46, no. 1933, p. 787, b814) (CBETA, T46, no. 1915, p. 462, a6~27) 1 (CBETA, T46, no. 1934, p. 793, a6) (CBETA, T51, no. 2076, p. 431, a29~b29) 1 (CBETA, T50, no. 2050, p. 196, a1417) 1 (CBETA, T16, no. 676, p. 692, c2223) 1 (CBETA, T14, no. 475, p. 538, b26c5) (CBETA, T46, no. 1911, p. 100, c1~29) 1 (CBETA, T08, no. 223, p. 219, a2026) 1 (CBETA, T46, no. 1923, p. 630, c1821) 1 (CBETA, T50, no. 2047a, p. 185, a28b2) 16 (CBETA, T50, no. 2060, p. 552, b17c1) Robert G.Allen(2003) MSI TEAM TAIMAN. (1998) 170
171 (2000) 21 (1993) (1999) Bill Moyers (1999) (1995) ( 1998) (Thorwald Dethlefsen) (Rudiger Dahlke)(2002) (1977) (1999) (1997) (1997) (Peter M.Senge) (2004). (Peter M.senge) (1995) () (2002) (1985) (1981) (2002) 15 (1965) (1995) (1981) (1993) (2000) (2002) (2000) (2000) (2002) (2000)
(2001) 2001 5 (2003) (2003) (1994) 173-183 http://ccbs.ntu.edu.tw/fulltext/jr-misc/mag61189.htm (1996) (pp179-193) http://ccbs.ntu.edu.tw/fulltext/jr-an/an018_08.htm (1979) 57 (1996) http://ccbs.ntu.edu.tw/fulltext/jr-an/an018_02.htm (1993) http://ccbs.ntu.edu.tw/fulltext/jr AN/an011_07.htm ISECO http://www.iseco.org.tw/about_israel_his_05.htm2006 2 28 WHO 2006/07/02@http://udn.com WHO 2006/07/02@http://udn.com http://www.epochtimes.com. http://www.windrug.com/pic/30/11/25/140.htm2005 7 26 http://www.woosee.com/yyty/fanchang.htm2005 8 7 SARS http://sars.bamboo.hc.edu.tw/spread_2.html http://w1.southnews.com.tw/modules.php?name=news&file=article&sid=14 72006 2 26 22 2003 6 172
http://www.casad.ac.cn/the_whole_web_root/chinese/yslt/yslt_brow.asp?id= 1602003/6/18 911 http://www.epochtimes.com/b5/2/9/10/n214398.htm2002/9/10 (2002). \ \ \ \ \ http://www.ebud.cn/book/book/h-readari.asp?no=48360 http://www.yzdxyz.com/source/lenwun/%c1%ce%c1%e1%c8%aa.doc http://www.people.com.cn/digest/200106/29/jk062903.html2005 7 25 http://www.uhealthy.com/cancer chinese/cervicalp2.htm http://www.nhi.gov.tw/webdata/webdata.asp?menu=6&menu_id=168&webd ata_id=13432006 1 13 SARS (http://sars.bamboo.hc.edu.tw/ ) SARS (WHO) WHO (2003/5/5) SARS HTTP://SARS.BAMBOO.HC.EDU.TW/SYMPOTON_2.HTML 2003/05/25 SARS HTTP://SARS.BAMBOO.HC.EDU.TW/2003/05/31 Taiwan News 174 p.38http://www1.pu.edu.tw/~hycheng/5paper/2005feb.html CBETA (2005 11 ). 173
A (structure) struere ( ) 174
(archetype ). (Shifting the Burden) 175
2.21 176
2.22 177
2.23 178
2.24 179
2.25 180
B 2003 SARS 2003 SARS 328 2003 SARS 3.11 SARS / 3.11 SARS 2003 1 2003 9 4 SARS 2003 9 4 (1)(6) SARS 181
664 SARS 3.12 SARS / 3.12 SARS SCISCAPE wcchou Apr 09, 2003 SARS SARS 182
183
1 SARS 没 隣 SARS 5 138 3.6% 76 55.1% 138 (100%) () 徧 (100%) Lancet 1425 SARS 94 331 SARS SARS SARS (metapneumovirus, paramyxoviridae ) (coronavirus) 92.05.25 184
SARS SARS SARS 332 SARS SARS 92 5 7 Lancet Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong, Lancet, May 7, 2003. SARS 1,425 SARS 92 2 20 4 23 SARS 3 10 SARS 3 27 ( 100 ) 4 23 20 SARS SARS Lancet WHO 1,425 SARS 90 94 ( ) 72.3 65.4 64.3 54.6 50.8 50.8 50.1 43.7 30.7 30.6 27.8 27.8 27.0 24.6 23.1 22.2 14.0 12.6 + 87.6 + 80.3 + 70.7 185
60 70 5 57 6.37 variance 16.69 95 5.297.75 95 14.22 12/263/2523/264/13 4/24/15 3.2 Lancet SARS 186
60 70 5 (1) SARS (2) (3) 60 70 5 (4) 5% 5% 5% 0.05% 0.005% 100% SARS SARS (WHO) SARS SARS SARS (WHO) 187
3.22SARS 188
189
(1) (2) 56 C (15 1 ) (3) ( 12%) 100 mg/l (0.01% ) 1% 5% WHO 1 56 C 2 formaldehyde ethanol acetone 250 250nm UV SARS 334 190
SARS SARS 1 335 2 SARS 3 56 C 4 nebuliser) BIPAP SARS SARS airborne 191
没 SARS SARS 336 SARS 1 N95 100 5 100 2 SARS 100 337 SARS SARS SARS 2003 5 SARS SARS SARS SARS CC SARS 338 192
3.23SARS 没 没 193
SARS SARS SARS 2 194
195
1 2 92 03 30 196
SARS 却 SARS SARS 没 SARS SARS SARS SARS 197
198
30% 30% SARS SARS SARS SARS C112 199
200
(1) ( ) SARS (2) C112 (3) SARS (4) 厠 厠 (5) (6) (A) (B) Air China (7) Air China SARS WHO Air China Air China 却 201
SARS ( ) ( () 12%) SARS SARS SARS 202